Abstract 666: RNAi Therapeutics Targeting Human Angiotensinogen (hAGT) Ameliorate Preeclamptic Sequelae in an Established Transgenic Rodent Model for Preeclampsia
暂无分享,去创建一个
S. Milstein | B. Bettencourt | G. Hinkle | K. Charissé | J. Bercher | R. Dechend | D. Müller | S. Kuchimanchi | N. Haase | M. Golic | L. Przybyl | Donald J. Foster | Julianna Rugor